Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Author:

Koshkin Vadim S.1ORCID,Henderson Nicholas2,James Marihella3,Natesan Divya1,Freeman Dory4,Nizam Amanda5,Su Christopher T.2ORCID,Khaki Ali Raza67ORCID,Osterman Chelsea K.8,Glover Michael J.7,Chiang Ryan7,Makrakis Dimitrios6,Talukder Rafee6,Lemke Emily9,Olsen T. Anders10,Jain Jayanshu11,Jang Albert12,Ali Alicia2,Jindal Tanya1,Chou Jonathan1ORCID,Friedlander Terence W.1,Hoimes Christopher13,Basu Arnab14,Zakharia Yousef11,Barata Pedro C.12ORCID,Bilen Mehmet A.10,Emamekhoo Hamid15ORCID,Davis Nancy B.16,Shah Sumit A.7,Milowsky Matthew I.8ORCID,Gupta Shilpa5,Campbell Matthew T.3,Grivas Petros6ORCID,Sonpavde Guru P.4,Kilari Deepak9ORCID,Alva Ajjai S.2

Affiliation:

1. Helen Diller Family Cancer Center University of California San Francisco San Francisco California

2. Rogel Comprehensive Cancer Center University of Michigan Ann Arbor Michigan

3. The University of Texas MD Anderson Cancer Center Houston Texas

4. Dana‐Farber Cancer Center Boston Massachusetts

5. Taussig Cancer Institute Cleveland Clinic Cleveland Ohio

6. Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center University of Washington Seattle Washington

7. Stanford University Stanford California

8. Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill North Carolina

9. Medical College of Wisconsin Milwaukee Wisconsin

10. Winship Cancer Institute of Emory University Atlanta Georgia

11. University of Iowa Iowa City Iowa

12. Tulane University Medical School New Orleans Louisiana

13. Duke University Durham North Carolina

14. University of Alabama at Birmingham Birmingham Alabama

15. University of Wisconsin Madison Wisconsin

16. Vanderbilt‐Ingram Cancer Center Nashville Tennessee

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3